These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8286992)

  • 21. Public health issues in treating tobacco use.
    Mecklenburg RE
    Am J Med Sci; 2003 Oct; 326(4):255-61. PubMed ID: 14557745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smokeless tobacco intervention.
    Manske K
    Dent Econ; 1998 Feb; 88(2):60, 62-5. PubMed ID: 9709581
    [No Abstract]   [Full Text] [Related]  

  • 23. Smokeless tobacco use in the United States: health implications and policy options.
    Backinger CL; Corbin SB; Furman LJ
    J Public Health Policy; 1988; 9(4):485-502. PubMed ID: 3069869
    [No Abstract]   [Full Text] [Related]  

  • 24. Smokeless tobacco cessation intervention for college athletes: results after 1 year.
    Walsh MM; Hilton JF; Masouredis CM; Gee L; Chesney MA; Ernster VL
    Am J Public Health; 1999 Feb; 89(2):228-34. PubMed ID: 9949754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smokeless tobacco: the health consequences of snuff and chewing tobacco.
    Goolsby MJ
    Nurse Pract; 1992 Jan; 17(1):24, 28, 31, passim. PubMed ID: 1538836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dentists nationwide are finding a new way to help tobacco chewers practice safe snuff.
    J Gt Houst Dent Soc; 1992 Mar; 63(8):28-9. PubMed ID: 1622567
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of behavioral and pharmacological treatment on smokeless tobacco users.
    Hatsukami D; Jensen J; Allen S; Grillo M; Bliss R
    J Consult Clin Psychol; 1996 Feb; 64(1):153-61. PubMed ID: 8907095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
    Els C
    J Psychiatry Neurosci; 2004 May; 29(3):240. PubMed ID: 15173898
    [No Abstract]   [Full Text] [Related]  

  • 29. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
    Fagerström KO; Tejding R; Westin A; Lunell E
    Tob Control; 1997; 6(4):311-6. PubMed ID: 9583629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of smokeless tobacco among adults--United States, 1991.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(14):263-6. PubMed ID: 8459796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Federal regulation of tobacco products and products that treat tobacco dependence: are the playing fields level?
    Page JA
    Food Drug Law J; 1998; 53 suppl():11-42. PubMed ID: 10342979
    [No Abstract]   [Full Text] [Related]  

  • 32. Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy.
    Burgess DJ; Fu SS; Noorbaloochi S; Clothier BA; Ricards J; Widome R; van Ryn M
    Nicotine Tob Res; 2009 Dec; 11(12):1439-47. PubMed ID: 19875765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DON'T QUIT ON YOUR SMOKERS. Persistence pays off when it comes to free nicotine replacement.
    Castelli G
    W V Med J; 2016; 112(2):13. PubMed ID: 27025112
    [No Abstract]   [Full Text] [Related]  

  • 35. [Smoking, nicotine dependence and detoxification therapies].
    Finnish Association of General Practitioner's task force
    Duodecim; 2002; 118(24):2578-87. PubMed ID: 12572294
    [No Abstract]   [Full Text] [Related]  

  • 36. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The organizational implications of smokeless tobacco use in the lumber mill industry.
    Donaldson SI; Dent CW; Sussman S; Stoddard JL; Severson HH
    Addict Behav; 1996; 21(2):259-67. PubMed ID: 8730529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of smokeless tobacco addiction with bupropion and behavior modification.
    Berigan TR; Deagle EA
    JAMA; 1999 Jan; 281(3):233. PubMed ID: 9918477
    [No Abstract]   [Full Text] [Related]  

  • 39. A pilot study of smokeless tobacco in smoking cessation.
    Tilashalski K; Rodu B; Cole P
    Am J Med; 1998 May; 104(5):456-8. PubMed ID: 9626029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cessation program for snuff-dippers with long-term, extensive exposure to Swedish moist snuff: A 1-year follow-up study.
    Wallström M; Bolinder G; Hassèus B; Hirsch JM
    Acta Odontol Scand; 2010 Nov; 68(6):377-84. PubMed ID: 20831357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.